Recently, a large cohort of mutational analysis on histological specimens was performed in 5125 Chinese patients and revealed that 36.2% and 8.4% patients with NSCLC carried EGFR and KRAS mutations respectively [21]. Here, KRAS is linked to non-small cell lung carcinoma.